Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines
Clinical trial NCT03506815 · COMPLETED
Trial details
- NCT number
- NCT03506815
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-15
- Primary completion
- 2020-05-14
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.